Onkoloji alan\u0131nda \u00f6nc\u00fc ara\u015ft\u0131rmalar ve klinik uygulamalarda \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmeler, The University of Texas MD Anderson Cancer Center\u2019dan be\u015f se\u00e7kin bilim insan\u0131n\u0131n Amerikan Kanser Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (AACR) 2025 Y\u0131ll\u0131k Toplant\u0131s\u0131 kapsam\u0131nda prestijli Bilimsel Ba\u015far\u0131 \u00d6d\u00fclleri ile onurland\u0131r\u0131laca\u011f\u0131n\u0131 m\u00fcjdeledi. Bu \u00f6nemli \u00f6d\u00fcller, s\u00f6z konusu bilim insanlar\u0131n\u0131n hem \u00e7evrim i\u00e7i hem de pratik onkoloji alan\u0131ndaki yenilik\u00e7i katk\u0131lar\u0131n\u0131 takdir ederken, MD Anderson\u2019\u0131n kanser biyolojisi, terap\u00f6tik yakla\u015f\u0131mlar ve biyoinformatik konular\u0131ndaki liderli\u011fini bir kez daha ortaya koyuyor.<\/p>\n
Dr. Robert Bast, deneysel terap\u00f6tikler alan\u0131ndaki ba\u015far\u0131l\u0131 \u00e7al\u0131\u015fmalar\u0131yla AACR-Daniel D. Von Hoff E\u011fitim ve Mentorluk \u00d6d\u00fcl\u00fc\u2019ne lay\u0131k g\u00f6r\u00fcld\u00fc. \u00d6zellikle over kanserinin erken tan\u0131s\u0131 ve takibinde devrim yaratan CA-125 biyobelirte\u00e7 ke\u015ffi, d\u00fcnya genelinde hasta bak\u0131m\u0131nda kaliteyi y\u00fckseltti. Bunun yan\u0131 s\u0131ra, gen\u00e7 ara\u015ft\u0131rmac\u0131lar\u0131n geli\u015fimine verdi\u011fi \u00f6nemle, detayl\u0131 yap\u0131land\u0131r\u0131lm\u0131\u015f mentorluk ve kariyer geli\u015ftirme programlar\u0131yla kendisinden sonraki neslin klinik ara\u015ft\u0131rmac\u0131 ve hekim-ara\u015ft\u0131rmac\u0131 olarak yeti\u015fmesini sa\u011flad\u0131. Dr. Bast\u2019\u0131n \u00e7abalar\u0131, translasyonel ara\u015ft\u0131rmalarda m\u00fckemmeliyet bilgisinin s\u00fcreklili\u011fini garanti alt\u0131na ald\u0131.<\/p>\n
Kanser biyolojisi alan\u0131nda \u00f6nc\u00fc isimlerden Dr. Ronald DePinho, ya\u015flanma ve kanser aras\u0131ndaki molek\u00fcler ba\u011flant\u0131lar\u0131 ayd\u0131nlatan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 \u00e7al\u0131\u015fmalar\u0131 nedeniyle AACR-Prenses Takamatsu An\u0131s\u0131na Konu\u015fma \u00d6d\u00fcl\u00fc\u2019n\u00fc almaya hak kazand\u0131. Genetik olarak tasarlanm\u0131\u015f modeller arac\u0131l\u0131\u011f\u0131yla, kromozomlar\u0131n koruyucu yap\u0131s\u0131 olan telomer biyolojisinin genomik karars\u0131zl\u0131k ve karsinogenezdeki kritik rol\u00fcn\u00fc ortaya koydu. Telomer erimesinin ya\u015fa ba\u011fl\u0131 epiteliyal kanserlerin geli\u015fimini nas\u0131l tetikledi\u011fine ili\u015fkin bulgular, ya\u015flanma s\u00fcre\u00e7lerinin tersine \u00e7evrilebilir oldu\u011funu g\u00f6sterdi ve bu da yeni tedavi stratejilerinin geli\u015ftirilmesine zemin haz\u0131rlad\u0131. Yakla\u015fan konferans konu\u015fmas\u0131nda, h\u00fccresel ya\u015flanma ile t\u00fcm\u00f6r olu\u015fumu aras\u0131ndaki karma\u015f\u0131k ili\u015fkiye dair \u00f6nemli bilgiler sunmas\u0131 bekleniyor.<\/p>\n
Hematolojik maligniteler alan\u0131nda, Dr. Christopher Flowers\u2019\u0131n lenfoma hastalar\u0131ndaki sosyodemografik fakt\u00f6rlerin hastal\u0131k seyri ve tedavi sonu\u00e7lar\u0131na etkisini inceleyen klinik ve toplum bazl\u0131 ara\u015ft\u0131rmalar\u0131, AACR-Minorities in Cancer Research Jane Cooke Wright Konu\u015fmas\u0131 \u00d6d\u00fcl\u00fc ile ta\u00e7land\u0131r\u0131ld\u0131. Dr. Flowers\u2019\u0131n yapt\u0131\u011f\u0131 geni\u015f \u00e7apl\u0131 kohort \u00e7al\u0131\u015fmalar\u0131 ve detayl\u0131 epidemiyolojik analizler, hastal\u0131k riskinin daha iyi s\u0131n\u0131fland\u0131r\u0131lmas\u0131n\u0131 sa\u011flarken, sa\u011fl\u0131k e\u015fitsizliklerinin giderilmesine y\u00f6nelik stratejilerin geli\u015ftirilmesine katk\u0131 sundu. Klinik ara\u015ft\u0131rmac\u0131 ve mentorluk rol\u00fc arac\u0131l\u0131\u011f\u0131yla, daha kapsay\u0131c\u0131 ve etkili lenfoma y\u00f6netimi ad\u0131na bilimsel bir topluluk olu\u015fturuyor.<\/p>\n
Kanser genomikleri ve biyoinformatik alan\u0131ndaki \u00f6nc\u00fc \u00e7al\u0131\u015fmalar\u0131yla tan\u0131nan Dr. Han Liang, Temel Kanser Ara\u015ft\u0131rmalar\u0131nda \u00dcst\u00fcn Ba\u015far\u0131 \u00d6d\u00fcl\u00fc ile onurland\u0131r\u0131ld\u0131. Hesaplamal\u0131 biyoloji uzman\u0131 olan Liang, \u00e7oklu omik veri entegrasyonuyla farkl\u0131 t\u00fcm\u00f6rlerde molek\u00fcler zay\u0131fl\u0131klar\u0131 haritaland\u0131ran pan-kanser analizlerinin \u00f6nc\u00fcl\u00fc\u011f\u00fcn\u00fc yapt\u0131. The Cancer Proteome Atlas ve kanser h\u00fccrelerinde uzun kodlamayan RNA\u2019lar (lncRNA\u2019lar) ile RNA d\u00fczenleme olaylar\u0131n\u0131 a\u00e7\u0131k eri\u015fimle incelemeye imkan tan\u0131yan TANRIC platformlar\u0131n\u0131 geli\u015ftirdi. Ayr\u0131ca, A\u2019dan \u0130 (A-to-I) RNA d\u00fczenlemesine ili\u015fkin ara\u015ft\u0131rmalar\u0131, t\u00fcm\u00f6r davran\u0131\u015f\u0131n\u0131 etkileyen ve tedavi direncine yol a\u00e7an post-transkripsiyonel de\u011fi\u015fiklikleri ayd\u0131nlatarak yeni tedavi hedeflerini g\u00fcn y\u00fcz\u00fcne \u00e7\u0131kard\u0131.<\/p>\n
Deneysel radyasyon onkolojisinde gelecek vaat eden bir isim olan Dr. Di Zhao, AACR 2025 Y\u0131ll\u0131k Toplant\u0131s\u0131\u2019n\u0131n SonrakiGen Star \u00f6d\u00fcl\u00fcne lay\u0131k g\u00f6r\u00fcld\u00fc. \u0130leri prostat kanserinin karma\u015f\u0131k biyolojisini anlamak i\u00e7in genetik m\u00fchendisli\u011fiyle olu\u015fturulmu\u015f modelleri ve tek h\u00fccre \u00e7ok-omik analizlerini bir arada kullanan \u00e7al\u0131\u015fmalar\u0131 ile dikkat \u00e7ekiyor. Tedaviye duyarl\u0131l\u0131klar\u0131 karakterize ederek, etkili kombinasyon terapileri geli\u015ftirmeye y\u00f6nelik translasyonel ara\u015ft\u0131rmalar\u0131, klinisyenlerle yak\u0131n i\u015fbirli\u011fi i\u00e7inde hasta odakl\u0131 tedavi bireyselle\u015ftirmesini destekliyor. Zhao\u2019n\u0131n \u00e7al\u0131\u015fmalar\u0131, ki\u015fiselle\u015ftirilmi\u015f onkolojide yeni bir d\u00f6nemin kap\u0131lar\u0131n\u0131 aral\u0131yor.<\/p>\n
Bu \u00f6d\u00fcller, kanser ara\u015ft\u0131rmalar\u0131nda disiplinleraras\u0131 i\u015fbirli\u011fi ve yenili\u011fe verilen \u00f6nemin artt\u0131\u011f\u0131 kritik bir d\u00f6nemde veriliyor. MD Anderson Ba\u015fkan\u0131 Dr. Peter WT Pisters, \u00f6d\u00fcl alan bilim insanlar\u0131n\u0131, bilimsel titizlik, d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc ke\u015fifler ve mentorluk a\u00e7\u0131s\u0131ndan \u00f6rnek olarak tan\u0131mlad\u0131. \u00d6d\u00fcl alanlar\u0131n uzmanl\u0131k alanlar\u0131 molek\u00fcler biyoloji, hesaplamal\u0131 analiz, klinik ara\u015ft\u0131rma ve terap\u00f6tik geli\u015ftirme gibi geni\u015f bir yelpazeyi kaplayarak, MD Anderson\u2019\u0131n kanserle m\u00fccadelede b\u00fct\u00fcnc\u00fcl ve entegratif yakla\u015f\u0131m\u0131n\u0131 yans\u0131t\u0131yor.<\/p>\n
MD Anderson\u2019\u0131n Bilimsel Direkt\u00f6r\u00fc Dr. Giulio Draetta ise, bu \u00f6d\u00fcllerin kurumun benzersiz i\u015fbirli\u011fi ortam\u0131n\u0131n bir yans\u0131mas\u0131 oldu\u011funu vurgulad\u0131. Temel bilimsel ara\u015ft\u0131rmalar, klinik deneyler ve e\u011fitim giri\u015fimlerinin kesi\u015fti\u011fi bir ekosistemin, kanser \u00f6nleme, tan\u0131, tedavi ve ya\u015fam kalitesini art\u0131rma alanlar\u0131nda devrim niteli\u011finde ilerlemelere \u00f6nc\u00fcl\u00fck etti\u011fine dikkat \u00e7ekti. Bu kolaboratif ortam, hasta sonu\u00e7lar\u0131n\u0131n iyile\u015ftirilmesi i\u00e7in kritik \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 \u00e7al\u0131\u015fmalara zemin haz\u0131rl\u0131yor.<\/p>\n
Bilimsel Ba\u015far\u0131 \u00d6d\u00fclleri ile e\u015f zamanl\u0131 olarak, deneysel terap\u00f6tikler profes\u00f6r\u00fc ve MD Anderson\u2019\u0131n terap\u00f6tik ke\u015fif ve klinik geli\u015ftirme ba\u015fkan\u0131 Dr. Timothy Yap\u2019\u0131n AACR\u2019nin sayg\u0131n dergisi Clinical Cancer Research\u2019\u0131n edit\u00f6rl\u00fc\u011f\u00fcne getirilmesi ve AACR Y\u00f6netim Kurulu \u00fcyeli\u011fine se\u00e7ilmesi de duyuruldu. Dr. Yap\u2019\u0131n ara\u015ft\u0131rma oda\u011f\u0131, molek\u00fcler hedefli tedaviler ve imm\u00fcnoterapilerin yenilik\u00e7i geli\u015fimi ile klinik deney s\u00fcre\u00e7lerinin h\u0131zland\u0131r\u0131lmas\u0131 \u00fczerine yo\u011funla\u015f\u0131yor. Yeni nesil prediktif biyobelirte\u00e7lerin ke\u015ffi ile tedavi etkinli\u011fi ve hasta se\u00e7iminin hassasla\u015ft\u0131r\u0131lmas\u0131nda \u00f6nemli ilerlemeler sa\u011fl\u0131yor.<\/p>\n
AACR 2025 Y\u0131ll\u0131k Toplant\u0131s\u0131, bu se\u00e7kin bilim insanlar\u0131n\u0131n \u00f6d\u00fcl konu\u015fmalar\u0131na ev sahipli\u011fi yaparak, daha geni\u015f onkoloji toplulu\u011funun yenilik\u00e7i bulgularla tan\u0131\u015fmas\u0131n\u0131 sa\u011flayacak. Bu etkinlik, kanserin \u00e7ok y\u00f6nl\u00fc zorluklar\u0131na kar\u015f\u0131 yeni hipotezlerin geli\u015ftirilebilece\u011fi ve uluslararas\u0131 i\u015fbirliklerinin do\u011fabilece\u011fi e\u015fsiz bir platform sunacak.<\/p>\n
MD Anderson Cancer Center\u2019\u0131n kanser inovasyonundaki \u00f6nc\u00fcl\u00fc\u011f\u00fc, laboratuvardan klinik uygulamaya h\u0131zl\u0131 ve etkin ge\u00e7i\u015fi hedefleyen translasyonel ara\u015ft\u0131rmalara verdi\u011fi stratejik \u00f6nemle paralellik g\u00f6steriyor. \u00d6d\u00fcllendirilen bilim insanlar\u0131n\u0131n ara\u015ft\u0131rmalar\u0131, t\u00fcm\u00f6r biyobelirte\u00e7 ke\u015ffinden telomer dinamiklerinin \u00e7\u00f6z\u00fcm\u00fcne; kanser sa\u011fl\u0131k e\u015fitsizliklerinden hesaplamal\u0131 genomik analizlere; deneysel radyasyon terapilerinden molek\u00fcler hedefli ila\u00e7 geli\u015ftirmeye kadar kritik alanlar\u0131 kaps\u0131yor. Bu farkl\u0131 uzmanl\u0131klar, kanser tedavisinde ki\u015fiselle\u015ftirilmi\u015f, hedefe y\u00f6nelik yakla\u015f\u0131mlara do\u011fru ilerlemede kilit rol oynuyor.<\/p>\n
Toplum faydas\u0131na y\u00f6nelik olarak, \u00f6d\u00fcl alan ara\u015ft\u0131rmac\u0131lar\u0131n \u00e7abalar\u0131 e\u011fitim, mentorluk ve disiplinleraras\u0131 ara\u015ft\u0131rman\u0131n entegrasyonuyla birle\u015ferek, hastalar i\u00e7in d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc sonu\u00e7lar do\u011furmay\u0131 hedefliyor. \u00c7al\u0131\u015fmalar, sadece ayr\u0131 bilimsel alanlarda ilerlemeleri de\u011fil, ayn\u0131 zamanda yetenek geli\u015ftirme, hesaplamal\u0131 teknolojilerin geli\u015ftirilmesi ve farkl\u0131 bak\u0131\u015f a\u00e7\u0131lar\u0131n\u0131 t\u00fcm\u00f6r biyolojisi \u00fczerine uygulamay\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor. B\u00f6ylece k\u00fcresel \u00e7apta kanser y\u00fck\u00fcn\u00fcn azalt\u0131lmas\u0131na y\u00f6nelik sa\u011flam ad\u0131mlar at\u0131l\u0131yor.<\/p>\n
Kanser ara\u015ft\u0131rmalar\u0131 camias\u0131, AACR 2025 Y\u0131ll\u0131k Toplant\u0131s\u0131\u2019nda bu d\u00f6rt bir yanl\u0131 \u00e7al\u0131\u015fmalar\u0131 ve \u00f6d\u00fcl alan bilim insanlar\u0131n\u0131n katk\u0131lar\u0131n\u0131 b\u00fcy\u00fck bir heyecanla bekliyor. MD Anderson Cancer Center\u2019\u0131n y\u0131ld\u0131z\u0131 parlayan bu se\u00e7kin kadrosu, hastalar\u0131n ya\u015fam s\u00fcrelerini uzatmak, ya\u015fam kalitesini y\u00fckseltmek ve nihayetinde kanseri \u00f6nleme ile yok etme yolunda yeni ufuklar a\u00e7\u0131yor. Onkoloji alan\u0131nda \u00f6nc\u00fc bu bilim insanlar\u0131, uluslararas\u0131 t\u0131bb\u0131n geli\u015fimine olan katk\u0131lar\u0131yla gelecek nesillere umut \u0131\u015f\u0131\u011f\u0131 olmaya devam ediyor.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Kanser translasyonel ara\u015ft\u0131rmalar\u0131, molek\u00fcler onkoloji, kanser genomikleri, biyobelirte\u00e7 ke\u015ffi, telomer biyolojisi, lenfoma klinik ara\u015ft\u0131rmalar\u0131, biyoinformatik, deneysel radyasyon onkolojisi, kanser terap\u00f6tik geli\u015ftirme.<\/p>\n Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: MD Anderson Scientists Receive Prestigious AACR Scientific Achievement Awards Ahead of the 2025 Annual Meeting<\/p>\n Web References<\/strong>: Anahtar Kelimeler<\/strong>: Kanser ara\u015ft\u0131rmalar\u0131, translasyonel onkoloji, kanser biyobelirte\u00e7leri, telomer biyolojisi, lenfoma sa\u011fl\u0131k e\u015fitsizlikleri, biyoinformatik, kanser genomikleri, ki\u015fiselle\u015ftirilmi\u015f t\u0131p, deneysel terap\u00f6tikler, radyasyon onkolojisi, AACR \u00f6d\u00fclleri, MD Anderson<\/p>\n","protected":false},"excerpt":{"rendered":" Onkoloji alan\u0131nda \u00f6nc\u00fc ara\u015ft\u0131rmalar ve klinik uygulamalarda \u00e7\u0131\u011f\u0131r a\u00e7an geli\u015fmeler, The University of Texas MD Anderson Cancer Center\u2019dan be\u015f se\u00e7kin bilim insan\u0131n\u0131n Amerikan Kanser Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (AACR) 2025 Y\u0131ll\u0131k Toplant\u0131s\u0131 kapsam\u0131nda prestijli Bilimsel Ba\u015far\u0131 \u00d6d\u00fclleri ile onurland\u0131r\u0131laca\u011f\u0131n\u0131 m\u00fcjdeledi. Bu \u00f6nemli \u00f6d\u00fcller, s\u00f6z konusu bilim insanlar\u0131n\u0131n hem \u00e7evrim i\u00e7i hem de pratik onkoloji alan\u0131ndaki yenilik\u00e7i katk\u0131lar\u0131n\u0131…<\/p>\n","protected":false},"author":1,"featured_media":3416,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[2096,2092,2093,2094,2095],"tmauthors":[],"class_list":{"0":"post-3415","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-hematolojik-malignitelerde-sosyodemografik-faktorlerin-etkisi","9":"tag-md-anderson-kanser-arastirmalari-odulleri-2025","10":"tag-onkoloji-alaninda-translasyonel-arastirmalar","11":"tag-over-kanseri-ca-125-biyobelirtec-kesfi","12":"tag-telomer-biyolojisi-ve-kanser-yaslanma-baglantisi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/MD-Andersondan-5-Arastirmaciya-2025-Bilim-Odulu-1745265566.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3415"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3415\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3416"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3415"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nhttps:\/\/www.mdanderson.org\/newsroom\/aacr\u2013five-md-anderson-researchers-honored-with-2025-scientific-achievement-awards.h00-159775656.html
\nAACR Annual Meeting 2025<\/p>\n